A carregar...
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is effective in the treatment of human chronic lymphocytic leukaemia and mantle cell lymphoma. Recent data have shown that ibrutinib also blocks IgE‐dependent activation and histamine release in human basophils (BAs) and mast cells (MCs). T...
Na minha lista:
| Publicado no: | Vet Comp Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900099/ https://ncbi.nlm.nih.gov/pubmed/31286638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12520 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|